Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis

Published:2016-07 Issue: Volume:99 Page:128-130
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Whitfield Michael G.,Streicher Elizabeth M.,Dolby Tania,Simpson John A.,Sampson Samantha L.,Van Helden Paul D.,Van Rie Annelies,Warren Robin M.

Funder

National Institutes of Health

South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation

National Institute of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference16 articles.

1. Global tuberculosis report Geneva;World Health Organization,2015

2. The curious characteristics of pyrazinamide: a review;Zhang;Int J Tuberc Lung Dis,2003

3. WHO treatment guidelines for drug-resistant tuberculosis 2016 update Geneva,2016

4. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

5. Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide;Chedore;J Clin Microbiol,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance to pyrazinamide in Mycobacterium tuberculosis complex isolates from previously treated tuberculosis cases in Southwestern Oromia, Ethiopia;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-02

2. Global status of phenotypic pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates: an updated systematic review and meta-analysis;Journal of Chemotherapy;2023-05-21

3. Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update;Current Microbiology;2022-10-08

4. Pyrazinamide resistance in rifampicin discordant tuberculosis;PLOS ONE;2022-09-21

5. Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis;Journal of Clinical Microbiology;2022-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3